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Aim: To test the utility of plasma D-dimer determination in the diagnosis of acute aortic
dissection (AAD), in particular with respect to its high negative predictive value reported in
the relevant literature.
Method: We performed a retrospective analysis of the medical records of 76 patients
admitted for acute chest pain of unclear etiology (of this number, 41 AAD patients and 35
controls with undocumented AAD) who had their plasma D-dimer levels determined on
admission. Using imaging techniques, AAD was documented in the 41 AAD patients by
computer tomography (80%), esophageal echocardiography (18%), aortography or based on
pathological–anatomical autopsy ﬁndings (one patient each).
Results: The ﬁnding of increased D-dimer levels (40.5 mg/l FEU) showed 100% sensitivity,
i.e., a 100% negative predictive value, 37% speciﬁcity, 65% positive predictive value, and
71% accuracy in diagnosing AAD. Elevated D-dimer levels correlated with more extensive
involvement of the aorta consistent with the type of dissection using De Bakey's
classiﬁcation (II, III, I; r¼0.63; po0.01). No correlation was found between plasma D-
dimer levels and chest pain duration.
Conclusion: Determination of plasma D-dimer levels seems to be a useful tool in early
diagnosis of AAD. Plasma D-dimer levels o0.5 mg/l FEU virtually exclude the presence
of AAD.
& 2013 The Czech Society of Cardiology. Published by Elsevier Urban & Partner Sp.z o.o. All
rights reserved.
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Acute aortic dissection (AAD) is a relatively uncommon, yet
life-threatening condition. Its early diagnosis and manage-
ment are thus absolutely critical for a successful outcome [1].
Recognition of AAD consists in proper baseline assessment of
its clinical presentations and subsequent corroboration using
imaging techniques [2]. However, given the wide range of
potential clinical presentations and variable availability
of imaging techniques, use of this strategy still leaves
30–40% of cases of AAD undiagnosed. This explains why the
condition is often not documented until pathological–anato-
mical autopsy [3]. It was for this reason that attention has
focused, in recent years, on the identiﬁcation of biomarkers
that would make the diagnosis of AAD more accurate. While
determination of soluble elastin fragments [4] or myosin
heavy chains [5] has been shown to have high sensitivity
and speciﬁcity in ADD diagnosis, it is currently unfeasible in
everyday clinical practice. By contrast, determination of
plasma D-dimers is a readily available procedure repeatedly
shown to have high sensitivity in diagnosing AAD compar-
able with that in documenting pulmonary embolism [6].
However, D-dimer levels may be little disease-speciﬁc in
recognizing AAD as elevated plasma D-dimer levels are also
seen in a variety of other pathological conditions. As data on
the utility of D-dimers in the diagnosis of AAD published to
date are largely inconsistent both in terms of the type and
duration of dissection, and the use of laboratory sets and,
particularly, control groups [6], the speciﬁcity of D-dimers
and their optimal cut-off levels in the diagnosis of AAD
remain unclear. The aim of our study was to compare
D-dimer levels in patients with documented AAD and in
individuals with suspected AAD in whom imaging techniques
ruled out the diagnosis.2. Method
2.1. Group of patients
We performed a retrospective analysis of the medical records
of a total of 138 consecutive patients examined for chest pain
and suspected AAD from March 2003 through May 2012 at the
Division of Acute Cardiology of the Department of Cardiology
of the Prague-based Institute for Clinical and Experimental
Medicine. The 138 individuals included 76 patients who had
their plasma D-dimer levels determined on baseline exam-
ination. The diagnosis of AAD was conﬁrmed in 41 patients
and excluded in the remaining 35 patients using computer
tomography (80%), esophageal echocardiography (18%), andaortography or based on ﬁndings of pathological–anatomical
autopsy (one patient each). The dissection was classiﬁed as
acute if lasting less than 2 weeks since the onset of symp-
toms [2]. The type of dissection was determined using
Standford [13] and De Bakey classiﬁcation systems [8].
2.2. Biochemical analysis
Plasma D-dimer levels were determined quantitatively using
one of the four commercially available assays based on
turbidimetry of microlatex particles: the INNOVANCE
D-Dimer assay (Siemens Medical Solutions, Erlangen, Germany)
with a DadeBehring BSC analyzer (DadeBehring, Glasgow, UK) in
23% of patients; the Liatest D-DI (DiagnosticaStago, New Jersey,
USA) with a STA-R Evolution analyzer (DiagnosticaStago) in 47%
of patients; the Coamatic D-Dimer (Chromogenix) with the
DadeBehring BCS analyzer in 23%; and the D-Dimer plus
(DadeBehring) with the DadeBehring BCS analyzer in 7% of
patients. The upper cut-off levels for all assays levels were
0.5mg/l ﬁbrinogen equivalent units (FEU) (D-dimer levels above
this value were considered positive).
2.3. Statistical analysis
Continuous variables are expressed by descriptive statistics
and compared using the Student t-test or the Mann–Whitney
test depending on the normal distribution pattern. Catego-
rical variables are expressed by their relative frequency and
were compared using the chi-square test or Fisher's exact
test. The reliability of D-dimer determination in diagnosing
AAD was evaluated using the ROC analysis. Statistical ana-
lyses were performed using SPSS 16.0 software (SPPS). Values
were considered statistically signiﬁcant if po0.05.3. Results
3.1. Clinical presentation and ﬁndings of imaging
techniques
Table 1 shows the characteristics of our study group. Using
the Standford classiﬁcation, 36 patients (88%) had Type A
dissection while ﬁve patients (12%) had Type B dissection,
which was not related with palpability of femoral artery.
After ruling out suspected AAD, the following diagnoses were
established in the control group: chest pain of musculoske-
letal etiology (n¼19), acute coronary syndrome (n¼6), peri-
myocarditis (n¼1), mediastinal tumor (n¼1), and acute
thrombosis of mechanical aortic valve prosthesis (n¼1),
pancreatitis (n¼1), gastric ulcer perforation (n¼2), large
Table 1 – Characteristics of the study group.
Parameter Acute dissection (n¼41) Control group (n¼35) p
Age (years) 60713 61712 0.76
Males (%) 19 (46)% 19 (54)% 0.47
Patient history
Duration of chest pain (h) 12 [3–24] 12 [3–45] 0.51
Arterial hypertension 33 (81)% 27 (77)% 0.72
Coronary heart disease 6 (15)% 8 (23)% 0.36
Extracardiac atherosclerosisa 0 (0)% 10 (29)% 0.006n
Treated diabetes mellitus 2 (5)% 8 (23)% 0.037
Previous chest surgeryb 5 (12)% 4 (11)% 0.92
Marfan's syndrome 3 (7)% 2 (6)% 1.00
Smoking 12 (39)% 9 (33)% 0.63
Treated dyslipidemia 6 (15)% 12 (35)% 0.037
Physical ﬁnding
Murmur of aortic regurgitation 8 (20)% 1 (3)% 0.032n
Side-to-side pulsation difference in limbsc 14 (35)% 0 (0)% 0.001nn
Systolic blood pressure (mmHg) 137738 145729 0.30
Diastolic blood pressure (mmHg) 73719 77717 0.29
Heart rate 79722 85730 0.29
Laboratory data
D-dimer (mg/l FEU) 5.8 [1.2–20.1] 0.7 [0.3–2.2] o0.001nnn
D-dimer positive (40.5 mg/l FEU) 41 (100)% 22 (63)% 0.001nn
Fibrinogen (g/l) 3.771.9 4.271.3 0.19
C-reactive protein (mg/l) 11.7 [2.0–44] 4.0 [2.0–4.9] 0.85
Leukocyte count ( 109/l) 12.474.0 10.975.7 0.21
Hemoglobin (g/l) 130724 137722 0.23
n Po0.05.
nn Po0.005.
nnn Po0.001.
a Symptomatic lower limb involvement or ischemic stroke in history.
b Any on-pump surgery involving thoracic aorta clamping.
c Side-to-side difference 420 mmHg in the upper limbs of side-to-side difference in palpable pulsation in the radial artery or absence
of palpable pulsation in the femoral artery.
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without AAD (n¼1), coronary artery aneurysm (n¼1), and
chest pain of unidentiﬁed etiology (n¼1). Compared with the
control group, a signiﬁcantly smaller number of AAD patients
had a history of symptomatic peripheral arterial disease or
ischemic stroke (0% vs. 29%; p¼0.004). However, the sub-
groups did not differ in age, sex, and prevalence of the risk
factors for atherosclerosis (Table 1). Findings of diastolic
murmur above the precordium, side-to-side differences in
blood pressure in the upper limbs (420 mmHg) or absent
femoral artery pulsation, while relatively infrequent, were
highly AAD-speciﬁc (Table 1).
3.2. Laboratory test-based diagnosis
Quantitative determination of D-dimer levels has been
shown to be a most useful tool for diagnosing AAD. Fig. 1
contains the ROC curve showing the relation between the
sensitivity and speciﬁcity of the given test, with the area
under the ROC curve ([95% CI]¼0.82 [0.73–0.92]; po0.001).
Elevated D-dimer levels (40.5 mg/l FEU) have been shown to
have 100% sensitivity, and hence a 100% negative predictive
value, 37% speciﬁcity, 65% positive predictive value, and 71%accuracy for diagnosing AAD. While setting the cut-off value
of 1.0 mg/L FEU resulted in 59% speciﬁcity, this was at the
cost of decreasing sensitivity to 83%. Increased D-dimer levels
correlated with more extensive involvement of the aorta,
consistent with the dissection type according to the De Bakey
classiﬁcation (in the following sequence: II, III, I; r¼0.63;
po0.01; Fig. 2). At the same time, no correlation was found
between D-dimer levels and chest pain duration. The other
routinely determined laboratory parameters indicating coa-
gulation activity (ﬁbrinogen), inﬂammation (C-reactive pro-
tein, leukocyte count, and ﬁbrinogen) or any anemization
(hemoglobin) were not helpful in diagnosing AAD (Table 1).
3.3. Clinical course
Thirty-day mortality was evaluated in 29 AAD patients. Acute
surgery or, possibly, implantation of a stent graft into the
aorta, was undertaken in 23 patients with AAD (79%). While
three patients with Type B dissection were initially indicated
for conservative therapy, three other patients with Type A
dissection experienced rapid deterioration of their condition
and died before surgery. Overall, there were six in-hospital
deaths related to AAD (20%), and all of the dying patients
c o r e t v a s a 5 5 ( 2 0 1 3 ) e 5 1 0 – e 5 1 4 e513have extensive dissection. The deceased AAD patients were
shown to have – compared with survivors – higher D-dimer
levels (29.6 [15.9–42.6] vs. 5.2 [1.2–20.8] mg/l FEU; p¼0.013) and
lower baseline systolic blood pressure (102725 vs.
150738 mmHg; p¼0.008). The risk of 30-day mortality from
AAD (HR [95% CI]) rose by 1.1 with every increase by 1 mg/l
FEU of D-dimer levels (1–1.1; p¼0.039).Fig. 1 – ROC analysis of D-dimer levels in diagnosing acute
aortic dissection.
Fig. 2 – Correlation between D-dimer levels and extent of
aortic involvement.4. Discussion
The present study attests to the utility of plasma D-dimer
level determination in the diagnosis of AAD in a pre-selected
patient population with suspected AAD as part of the differ-
ential diagnosis of acute chest pain. Our results suggest the
importance of D-dimer determination lies mainly in its
negative predictive value. Plasma D-dimer levels o0.5 mg/l
FEU virtually rule out the diagnosis of AAD.
Our results are consistent with data reported earlier [6].
However, an issue for future debate is the relatively low
speciﬁcity of plasma D-dimer level determination for estab-
lishing the diagnosis of AAD, due primarily to the composi-
tion of the control population. On the one hand, there are
papers comparing D-dimer levels in AAD patients with those
in pre-deﬁned patient groups with documented myocardial
infarction, lung embolism or pain of unclear etiology [7,9]. In
these cases, the speciﬁcity of D-dimer levels o0.5 mg/l FEU
was in the range of 69–73%. On the other hand, studies
mimicking real-world conditions (similar to ours) report a
speciﬁcity ranging between 34% and 74% for the same
D-dimer cut-off values [10,11]. While not having, based on
the sample size, the statistical power to assess the prognostic
value of D-dimers in AAD, we did observe an association
between death from AAD and elevated D-dimer levels. This
ﬁnding is in line with that reported in another recent study
addressing the same issue [12]. The ﬁnding can be explained,
to a certain extent, by the positive correlation between
D-dimer levels and extent of dissection or shorter duration
(i.e., higher acuteness) of symptoms.
As regards clinical practice, it should be noted that,
despite numerous studies consistently documenting high
sensitivity of D-dimers in the diagnosis of AAD, the role of
this test has not yet been clearly deﬁned. For example, the
current guidelines of the American Heart Association,
together with those of other professional societies, do not
explicitly recommend this assay in patients with high suspi-
cion of acute aortic syndrome referring to potentially low
D-dimer levels particularly in patients with intramural hema-
toma [1]. While the European Society of Cardiology guidelines
do not speciﬁcally address the issue of D-dimer determina-
tion in the diagnosis of AAD [2], the Czech Society of
Cardiology has not published any guidelines for the diagnosis
and treatment of AAD to date.
4.1. Study limitations
A limitation of our study was the relatively small number of
patients, but large enough in comparison with other studies
[7,9], reﬂecting among other factors, the relatively rare
occurrence of this diagnosis and fairly infrequent use ofD-dimer level determination in routine differential diagnosis
of chest pain (performed, in our group, in only 55% of
patients examined for suspected AAD). The reason for
considering acute aortic dissection only infrequently as a
potential cause of problems in the differential diagnosis of
chest pain in everyday clinical practice may be due to just
another fact. Ours is a retrospective analysis of data from
routine clinical practice of a referral cardiovascular center,
with a proportion of patients referred from another depart-
ment for suspected AAD. The decision to have the patient
examined by imaging techniques was left to the discretion
of the attending physician who had the results of D-dimer
determination at their disposal. Nonetheless, as suggested
by personal communication, most physicians establishing
or excluding the diagnosis of AAD were not guided by
D-dimer levels anyway.
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Results of our retrospective analysis support literary reports
suggesting determination of plasma D-dimer levels should
become part of routine assessment in all patients experien-
cing acute chest pain of unclear etiology. Plasma D-dimer
levels o0.5 mg/l FEU virtually rule out the diagnosis of AAD.
By contrast, higher D-dimer levels do correlate with more
extensive involvement of the aorta by acute dissection.
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